<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04280510</url>
  </required_header>
  <id_info>
    <org_study_id>C19-07</org_study_id>
    <secondary_id>2019-A01594-53</secondary_id>
    <nct_id>NCT04280510</nct_id>
  </id_info>
  <brief_title>Pathogenic Study of Adult Immune Enteropathies</brief_title>
  <acronym>ENTEROPAH</acronym>
  <official_title>Pathogenic Study of Adult Immune Enteropathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Imagine Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac
      disease, refractory celiac disease and other immune diseases such as monogenic enteropathy,
      inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation
      of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be
      investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in
      liver associated diseases.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 27, 2020</start_date>
  <completion_date type="Anticipated">February 27, 2027</completion_date>
  <primary_completion_date type="Anticipated">February 27, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intestinal Lymphocytes count</measure>
    <time_frame>Baseline</time_frame>
    <description>Lymphocytes isolation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DNA sequencing</measure>
    <time_frame>Baseline</time_frame>
    <description>Targeted Next Generation sequencing</description>
  </primary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Celiac Disease</condition>
  <condition>Autoimmune Enteropathy</condition>
  <condition>Inflammatory Bowel Diseases</condition>
  <arm_group>
    <arm_group_label>Active coeliac patients</arm_group_label>
    <description>Patients with active coeliac disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treated coeliac patients</arm_group_label>
    <description>Patients with coeliac disease on gluten free diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sprue type I</arm_group_label>
    <description>Patients with refractory coeliac disease of type I</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sprue type II</arm_group_label>
    <description>Patients with refractory coeliac disease of type II</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intestinal Lymphoproliferations</arm_group_label>
    <description>Patients with intestinal lymphoproliferations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non coeliac enteropathies</arm_group_label>
    <description>Patients with non coeliac immune-mediated enteropathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without neoplastic or inflammatory intestinal disease</arm_group_label>
    <description>Patients without neoplastic or inflammatory intestinal disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Blood sample collection; gastrointestinal biopsy</intervention_name>
    <description>Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...</description>
    <arm_group_label>Active coeliac patients</arm_group_label>
    <arm_group_label>Intestinal Lymphoproliferations</arm_group_label>
    <arm_group_label>Non coeliac enteropathies</arm_group_label>
    <arm_group_label>Patients without neoplastic or inflammatory intestinal disease</arm_group_label>
    <arm_group_label>Sprue type I</arm_group_label>
    <arm_group_label>Sprue type II</arm_group_label>
    <arm_group_label>Treated coeliac patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients planned to have blood specimens and possible upper and/or lower digestive
        endoscopy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or over

          -  affiliated to social insurance

          -  signed informed consent

        Exclusion Criteria:

          -  pregnancy

          -  under guardianship

          -  not able to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georgia MALAMUT, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP, Université de Paris (Université Paris Descartes)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Georgia MALAMUT, MD, PhD</last_name>
    <phone>33 1 58 41 41 76</phone>
    <email>georgia.malamut@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nadine CERF-BENSUSSAN, MD, PhD</last_name>
    <phone>33 1 42 75 42 88</phone>
    <email>nadine.cerf-bensussan@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Yoram Bouhnik, MD, PhD</last_name>
      <email>yoram.bouhnik@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Yoram Bouhnik, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xavier Treton, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Iradj Sobhani, MD, PhD</last_name>
      <email>iradj.sobhani@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Iradj Sobhani, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélien Amiot, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bicêtre</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Franck Carbonnel, MD, PhD</last_name>
      <email>franck.carbonnel@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Franck Carbonnel, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Matthieu ALLEZ, MD, PhD</last_name>
      <email>matthieu.allez@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Matthieu Allez, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Laurent Beaugerie, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Laurent Beaugerie, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Georgia Malamut, MD, PhD</last_name>
      <email>georgia.malamut@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Georgia MALAMUT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stanislas CHAUSSADE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vered ABITBOL, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 20, 2020</study_first_submitted>
  <study_first_submitted_qc>February 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2020</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Celiac Disease</keyword>
  <keyword>Autoimmune enteropathy</keyword>
  <keyword>Primary immunodeficiency</keyword>
  <keyword>Intestinal lymphoma</keyword>
  <keyword>Liver autoimmune diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

